-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Pih4x+0JhTiiNQy+mvkaoflwroAfugcXX1sHED/ut3ro2Sr/3k95gs8giQ6vfI8e IAdmymIVSrD/CbqQUsRzmg== 0001181431-08-038284.txt : 20080611 0001181431-08-038284.hdr.sgml : 20080611 20080611180150 ACCESSION NUMBER: 0001181431-08-038284 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080609 FILED AS OF DATE: 20080611 DATE AS OF CHANGE: 20080611 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 SPEAR STREET, 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 201 SPEAR STREET, 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seely Lynn CENTRAL INDEX KEY: 0001327111 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 08894099 BUSINESS ADDRESS: BUSINESS PHONE: (415) 543-3470 MAIL ADDRESS: STREET 1: 501 2ND STREET STREET 2: SUITE 211 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 4 1 rrd210330.xml 06/09/08 10B5-1 SALE X0202 4 2008-06-09 0 0001011835 MEDIVATION, INC. MDVN 0001327111 Seely Lynn C/O MEDIVATION, INC. 201 SPEAR STREET, 3RD FLOOR SAN FRANCISCO CA 94105 0 1 0 0 Chief Medical Officer Common Stock 2008-06-09 4 M 0 9000 3.6 A 9000 D Common Stock 2008-06-09 4 S 0 9000 14.9362 D 0 D Option (right to buy) 3.6 2008-06-09 4 M 0 9000 0 D 2015-03-14 Common Stock 9000 306000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 9, 2007. The option is immediately exercisable, in whole or in part, and the shares subject to the option vest according to the following schedule: 25% of the shares subject to the option vested on March 14, 2006, and 1/48th of the shares subject to the option vested and continue to vest on the first day of each full month thereafter so that all of the shares subject to the option shall be fully vested on March 1, 2009. C. Patrick Machado, Attorney-In-Fact for Lynn Seely, M.D. 2008-06-11 -----END PRIVACY-ENHANCED MESSAGE-----